FrancophonIA/ELRC3.0 huggingface dataset:
English: Patients who received REYATAZ or REYATAZ/ritonavir at any time prior to study enrollment or who had a history of treatment failure on two or more protease inhibitors, protease inhibitor resistance or evidence of pre-existing cardiac abnormalities were excluded from the trials.
Croatian: Bolesnici koji su primali REYATAZ ili REYATAZ/ritonavir bilo kada prije uključivanja u ispitivanje ili su u anamnezi imali neuspjeh liječenja sa jedanim ili više inhibitora proteaze, rezistenciju na inhibitore proteaze, ili dokaz o postojećim srčanim abnormalnostima bili su isključeni iz ispitivanja.
English: Cases of osteonecrosis have been reported, particularly in patients with generally acknowledged risk factors, advanced HIV disease or long-term exposure to combination antiretroviral therapy (CART).
Croatian: Zabilježeni su slučajevi osteonekroze, osobito u bolesnika s općenito poznatim čimbenicima rizika, uznapredovalom HIV-bolešću ili dugotrajnom izloženošću kombiniranoj antiretrovirusnoj terapiji.
English: Week 48: -3% [-7.6%, 1.5%] Week 96: 2.2% [-2.3%, 6.7%] HIV RNA <50 copies/ml, % by Baseline Characteristicd HIV RNA <100,000 copies/ml
Croatian: 48. tjedan: -3% [-7,6%, 1,5%] 96. tjedan: 2,2% [-2,3%, 6,7%] HIV RNK <50 kopija/ml, % prema početnim značajkamad HIV RNK <100 000 kopija/ml
English: 100 mgd a The same recommendations regarding the timing and maximum doses of concomitant proton pump inhibitors and H2receptor antagonists in adults also apply to paediatric patients (see section 4.5).
Croatian: 100 mg d a Iste preporuke vezano uz vrijeme i maksimalnu dnevnu dozu istovremeno primijenjenog inhibitora protonske pumpe ili antagonista H2-receptora u odraslih također se primjenjuju na pedijattrijske bolesnike (vidjeti dio 4.5)
English: De novo substitutions in treatment naive patients failing therapy with atazanavir + ritonavir (Study 138, 96 weeks)
Croatian: De novo supstitucije u bolesnika koji prethodno nisu bili liječeni i u kojih je podbacila terapija atazanavirom + ritonavirom (Ispitivanje 138, 96 tjedana)
English: * Effect of atazanavir and ritonavir on the first dose of glecaprevir and pibrentasvir is reported.
Croatian: * Prijavljen je učinak atazanavira i ritonavira na prvu dozu glecaprevira i pibrentasvira.
English: Talk to your doctor or pharmacist before taking REYATAZ and make sure your doctor knows: if you have hepatitis B or C if you develop signs or symptoms of gall stones (pain at the right side of your stomach) if you have type A or B haemophilia if you require haemodialysis
Croatian: Obratite se svom liječniku ili ljekarniku prije nego uzmete REYATAZ i pobrinite se da liječnik zna: ako imate hepatitis B ili C ako se u Vas razviju znakovi ili simptomi žučnih kamenaca (bol na desnoj strani trbuha) ako imate hemofiliju tipa A B ako Vam je potrebna hemodijaliza
English: In clinical studies, REYATAZ (with or without ritonavir) has been shown to induce dyslipidaemia to a lesser extent than comparators.
Croatian: U kliničkim se ispitivanjima pokazalo da REYATAZ (s ili bez ritonavira) izaziva dislipidemiju u manjem opsegu nego drugi slični lijekovi.
English: In clinical trial AI424-182 REYATAZ/ritonavir (300/100 mg or 400/100 mg) in combination with zidovudine/lamivudine was administered to 41 pregnant women during the second or third trimester.
Croatian: U kliničkom je ispitivanju AI424-182 REYATAZ/ritonavir (300/100 mg ili 400/100 mg) u kombinaciji sa zidovudinom/lamivudinom bio primijenjen u 41 trudnice tijekom drugog ili trećeg tromjesečja.
English: The use of REYATAZ with ritonavir may be considered during pregnancy only if the potential benefit justifies the potential risk.
Croatian: Primjena lijeka REYATAZ s ritonavirom može se uzeti u obzir tijekom trudnoće samo ako moguća korist opravdava mogući rizik.
English: Place the syringe in your child's mouth towards the cheek and push the plunger down to release the medicine.
Croatian: Stavite štrcaljku u usta djeteta, unutar obraza i potisnite klip kako bi istisnuli lijek.
English: REYATAZ has not been studied in children less than 3 months of age and is not recommended because of the potential risk of kernicterus.
Croatian: REYATAZ nije ispitan u djece mlađe od 3 mjeseca starosti i ne preporučjue se zbog mogućeg rizika od kernikterusa.
English: A: To mix the recommended number of REYATAZ oral powder sachets with liquid infant formula in a small medicine cup or small container and to administer with an oral syringe, which can be obtained from a pharmacist: A spoon is used to mix the content of the appropriate number of sachets (4 or 5 sachets depending on infant weight) with 10 ml of prepared liquid infant formula in the medicine cup or small container.
Croatian: A: Za miješanje preporučenog broja vrećica REYATAZ oralnog praška, s tekućom dojenačkom formulom u maloj medicinskoj čaši ili malom spremniku za primjenu putem oralne štrcaljke koja se može dobiti od ljekarnika: Žlica se koristi kako bi se pomiješao sadržaj određenog broja vrećica (4-5 vrećica ovisno o tjelesnoj težini dojenčeta) s 10 ml pripremljene tekuće dojenačke formule u maloj medicinskoj čaši ili malom spremniku.
English: Some medicines may interact with ritonavir, a medicine that is taken with REYATAZ.
Croatian: Neki lijekovi mogu ući u interakciju s ritonavirom, koji se uzima zajedno s lijekom REYATAZ.
English: The safety profile in these studies was overall comparable to that seen in previous paediatric and adult studies.
Croatian: Sigurnosni profil u tim ispitivanjima općenito je bio usporediv s onime u prijašnjim pedijatrijskim ispitivanjima i ispitivanjima na odraslima.
English: common: fatigue; uncommon: chest pain, malaise, pyrexia, asthenia; rare: gait disturbance a These adverse reactions were identified through post-marketing surveillance, however, the frequencies were estimated from a statistical calculation based on the total number of patients exposed to REYATAZ in randomised controlled and other available clinical trials (n = 2321).
Croatian: često: umor; manje često: bol u prsištu, malaksalost, pireksija, astenija; rijetko: poremećaj hoda a Ove su nuspojave utvrđene u razdoblju nakon stavljanja lijeka u promet, premda, učestalost je procijenjena statističkim izračunom na temelju ukupnog broja bolesnika izloženih lijeku REYATAZ u randomiziranim kontroliranim i drugim dostupnim kliničkim ispitivanjima (n = 2321).
English: This association was observed independently of exposure to tenofovir disoproxil.
Croatian: Ta povezanost je primijećena neovisno o izloženosti tenofovirdizoproksilu.
English: 14-OH clarithromycin 14-OH clarithromycin AUC ↓70% 14-OH clarithromycin Cmax ↓72% 14-OH clarithromycin Cmin ↓62%
Croatian: 14-OH klaritromicin 14-OH klaritromicin AUC ↓70% 14-OH klaritromicin Cmax ↓72% 14-OH klaritromicin Cmin ↓62% (↓66%
English: Liver problems may uncommonly happen.
Croatian: Manje često se mogu pojavit problemi s jetrom.
English: In case of concomitant antiviral therapy for hepatitis B or C, please refer also to the relevant Summary of Product Characteristics for these medicinal products (see section 4.8).
Croatian: U slučaju istovremene antivirusne terapije zbog hepatitisa B ili C treba provjeriti odgovarajuće Sažetke opisa svojstava lijeka za te lijekove (vidjeti dio 4.8).
English: Weight and levels of blood lipids and glucose may increase during antiretroviral therapy (see section 4.4).
Croatian: Tjelesna težina i razine lipida i glukoze u krvi mogu biti povećane tijekom antiretrovirusne terapije (vidjeti dio 4.4.).
English: For the recommended paediatric dosage, REYATAZ oral powder contains 3915.45 mg sucrose per 150 mg atazanavir, 5220.60 mg sucrose per 200 mg atazanavir, 6525.75 mg sucrose per 250 mg atazanavir, and 7830.90 mg sucrose per 300 mg atazanavir.
Croatian: Kod preporučenih pedijatrijskih doza REYATAZ oralni prašak sadrži 3915,45 mg saharoze na 150 mg atazanavira, 5220,60 mg saharoze na 200 mg atazanavira, 6525,75 mg saharoze na 250 mg atazanavira i 7830,90 mg saharoze na 300 mg atazanavira.
English: PHARMACEUTICAL FORM AND CONTENTS Carton and label bottle pack (1 bottle): 60 hard capsules Blister pack: 60 hard capsules
Croatian: 4. FARMACEUTSKI OBLIK I SADRŽAJ Kutija i boca s naljepnicom (1 boca): 60 tvrdih kapsula Blister pakiranje: 60 tvrdih kapsula
English: Elimination: following a single 400 mg dose of 14C-atazanavir, 79% and 13% of the total radioactivity was recovered in the faeces and urine, respectively.
Croatian: Eliminacija: Nakon jednokratne doze od 400-mg 14C-atazanavira, 79% ukupne radioaktivnosti otkriveno je u stolici, a 13% u mokraći.
English: Stop taking REYATAZ and talk to your doctor immediately if you develop a severe rash or a rash with flu-like illness symptoms, blisters, fever, mouth sores, muscle or joint pain, swelling in the face, inflammation of the eye which causes redness (conjunctivitis), painful, warm, or red lumps (nodules).
Croatian: Odmah prestanite uzimati REYATAZ i obratite se liječniku ako se u Vas razviju teški osip ili ili osip sa simptomima bolesti nalik gripi mjehuriči, vrućica, ranice u ustima, bol u mišićima ili zglobovima, oticanje lica, upala oka koja uzrokuje crvenilo (konjunktivitis),bolni, topli ili crveni čvorići (noduli).
English: Atazanavir concentrations were greatly decreased when co-administered with didanosine (buffered tablets) and stavudine.
Croatian: Koncentracije atazanavira jako su se smanjile kad je primijenjen istovremeno s didanozinom (puferirane tablete) i stavudinom.
English: For young infants (less than 6 months) who cannot eat solid food or drink from a cup, REYATAZ oral powder should be mixed with infant formula and given using an oral syringe, which can be obtained from a pharmacist.
Croatian: Za mlađu dojenčad (mlađu od 6 mjeseci) koja ne može jesti krutu hranu ili piti iz čaše, REYATAZ oralni prašak može se pomiješati s dojenčakom formulom i dati pomoću oralne štrcaljke, koja se može zatražiti od ljekarnika.
English: Add 10 ml of prepared liquid infant formula and mix using a spoon.
Croatian: 2. Dodajte 10 ml pripremljene tekuće dojenačke formule i promiješatje koristeći žlicu.
English: Therefore, such coadministration is not recommended.
Croatian: Stoga se njihova istovremena primjena ne preporučuje.
English: Autoimmune disorders (such as Graves' disease and autoimmune hepatitis) have also been reported to occur in the setting of immune reactivation; however, the reported time to onset is more variable and these events can occurs many months after initiation of treatment.
Croatian: Pojava autoimunih poremećaja (poput Gravesove bolesti i autoimunog hepatitisa) također je bila prijavljena prilikom imunološke reaktivacije; međutim, prijavljeno vrijeme do nastanka je jako varijabilno, te ovi događaji mogu nastati puno mjeseci nakon početka liječenja.
English: 100 mgc aEach sachet contains 50 mg of REYATAZ bRitonavir oral solution cRitonavir oral solution or capsule/tablet
Croatian: 100 mg c aJedna vrećica sadrži 50 mg lijeka REYATAZ bRitonavir oralna otopina cRitonavir oralna otopina ili kapsule/tablete
English: Sildenafil, tadalafil, vardenafil Sildenafil, tadalafil, and vardenafil are metabolised by CYP3A4.
Croatian: Sildenafil, tadalafil, vardenafil Sildenafil, tadalafil i vardenafil metabolizira enzim CYP3A4.
English: Although not studied, there is a potential for an increase in pravastatin or fluvastatin exposure when coadministered with protease inhibitors.
Croatian: Iako interakcija nije ispitivana, postoji mogućnost povećane izloženosti pravastatinu ili fluvastatinu kada se primjenjuju zajedno s inhibitorima proteaze.
English: The risk of a further decrease in atazanavir exposure is expected when atazanavir is given with medicinal products known to reduce its exposure (e.g., tenofovir disoproxil or H2-receptor antagonists).
Croatian: Rizik od daljnjeg smanjenja izloženosti atazanaviru očekuje se kad se atazanavir daje s lijekovima za koje se zna da smanjuju izloženost atazanaviru (npr. tenofovirdizoproksil ili antagonisti H2-receptora).
English: The child is to drink the mixture.
Croatian: Dijete treba popiti mješavinu.
English: Choose the appropriate option listed below for giving REYATAZ oral powder to your child.
Croatian: 3. Izaberite odgovarajući način primjene REYATAZ oralnog praška naveden dolje za svoje dijete.
English: Method of administration: For oral use.
Croatian: Način primjene: Za peroralnu primjenu.
English: Systemic corticosteroid effects including Cushing's syndrome and adrenal suppression have been reported in patients receiving ritonavir and inhaled or intranasally administered fluticasone propionate; this could also occur with other corticosteroids metabolised via the P450 3A pathway, e.g., budesonide.
Croatian: Sistemski učinci kortikosteroida, uključujući Cushingov sindrom i supresiju nadbubrežne žlijezde, zabilježeni su u bolesnika koji su primali ritonavir i inhalirali ili intranazalno primjenjivali flutikazon propionat; to se može dogoditi i s drugim kortikosteroidima koji se metaboliziraju putem P450 3A, npr., budezonidom.
English: Difference estimate [95% CI]d
Croatian: Približna razlika [95% CI]d
English: Protease inhibitors: The co-administration of REYATAZ/ritonavir and other protease inhibitors has not been studied but would be expected to increase exposure to other protease inhibitors.
Croatian: Inhibitori proteaze: Istovremena primjena lijeka REYATAZ s ritonavirom i drugih inhibitora proteaze nije ispitana, ali pretpostavlja se da bi povećala izloženost drugim inhibitorima proteaze.
English: Elevation in ALT levels were more frequently reported in paediatric patients in these studies than in adults.
Croatian: Povišenje vrijednosti ALT je češće prijavljeno u ovim ispitivanjima u pedijatrijskih bolesnika nego u odraslih.
English: The use of REYATAZ may be considered during pregnancy only if the potential benefit justifies the potential risk.
Croatian: Primjena lijeka REYATAZ može se uzeti u obzir tijekom trudnoće samo ako moguća korist opravdava mogući rizik.
English: The mechanism of interaction between REYATAZ/ritonavir and sofosbuvir/velpatasvir/voxilaprevir is inhibition of OATP1B, Pgp, and CYP3A.
Croatian: Mehanizam interakcije između REYATAZ/ritonavir i sofosbuvir/velpatasvir/voksilaprevir je inhibicija OATP1B, Pgp, i CYP3A.
English: If an oral contraceptive is administered with REYATAZ/ritonavir, it is recommended that the oral contraceptive contain at least 30 μg of ethinyloestradiol and that the patient be reminded of strict compliance with this contraceptive dosing regimen.
Croatian: Ako se oralna kontracepcija primjenjuje s lijekom REYATAZ s ritonavirom preporučje se da oralna kontracepcija sadrži najmanje 30 μg etinilestradiola i da se bolesnici istakne važnost redovitog uzimanja kontracepcije kod ovog kontracepcijskog režima.
English: For treatment-naive paediatric patients,
Croatian: U prethodno liječenih pedijatrijskih bolesnika,
English: Efficacy data observed in the 41 paediatric patients aged 6 years to less than 18 years that received REYATAZ capsules with ritonavir are presented in Table 7.
Croatian: Podaci o djelotvornosti opaženoj u 41 pedijatrijskog bolesnika u dobi od 6 godina do manje od 18 godina koji su primali REYATAZ kapsule s ritonavirom prikazani su u tablici 7.
English: Co-administration of REYATAZ with ritonavir at doses greater than 100 mg once daily has not been clinically evaluated.
Croatian: Istovremena primjena lijeka REYATAZ s ritonavirom u dozama višima od 100 mg jedanput na dan nije klinički procijenjena.
English: The efficacy of REYATAZ/ritonavir in combination with tenofovir disoproxil fumarate in treatmentexperienced patients has been demonstrated in clinical study 045 and in treatment naive patients in clinical study 138 (see sections 4.8 and 5.1).
Croatian: Djelotvornost lijeka REYATAZ s ritonavirom u kombinaciji s tenofovirdizoproksilfumaratom u prethodno liječenih bolesnika dokazana je u kliničkom ispitivanju 045, a u bolesnika koji prethodno nisu bili liječeni u kliničkom ispitivanju 138 (vidjeti dijelove 4.8 i 5.1).
English: Diabetic population
Croatian: Dijabetička populacija
English: If you accidentally take or give more REYATAZ oral powder than your doctor recommended, contact your HIV doctor at once or contact the nearest hospital for advice.
Croatian: Ako slučajno uzmete ili date više REYATAZ oralnog praška nego što je preporučio Vaš liječnik, odmah se obratite liječniku ili potražite savjet u najbližoj bolnici.
English: Food effect: co-administration of REYATAZ and ritonavir with food optimises the bioavailability of atazanavir.
Croatian: Utjecaj hrane: Istovremena primjena lijeka REYATAZ i ritonavira s hranom optimizira bioraspoloživost atazanavira.
English: Interactions between atazanavir/ritonavir and protease inhibitors, antiretroviral agents other than protease inhibitors, and other non-antiretroviral medicinal products are listed in the table below (increase is indicated as “↑”, decrease as “↓”, no change as “↔”).
Croatian: Interakcije između atazanavira/ritonavira i inhibitora proteaze, amtiretrovirusnih lijekova koji nisu inhibitori proteaze i drugih lijekova koji nisu antiretrovirusni, navedene su u sljedećoj tablici (povišenje je označeno kao “↑”, sniženje kao “↓”, bez promjene kao “↔”).
English: *Ritonavir capsules, tablets or oral solution may be used.
Croatian: * Mogu se uzimati Ritonavir kapsule, tablete ili oralna otopina.
English: Do not use an infant bottle to give REYATAZ mixed with infant formula.
Croatian: Nemojte primjenjivati bocu za dojenče za primjenu lijeka REYATAZ pomiješanog s dojenačkom formulom.
English: Co-administration warrants clinical monitoring for sedation and cognitive effects.
Croatian: Istovremena primjena zahtijeva kliničko praćenje zbog sedacije i kognitivnih učinaka.
English: e Number of patients evaluable.
Croatian: e Broj bolesnika koje se moglo procijeniti.
English: Put another 10 ml of prepared infant formula in the cup or container and rinse the remaining oral powder from the cup or container.
Croatian: 5. Stavite dodatnih 10 ml pripremljene dojenačke formule u čašu ili spremnik i isperite ostatak oralnog praška iz čaše ili spremnika.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/03/267/001-006; 008-011
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/03/267/001-006; 008-011
English: Blister pack: 30 hard capsules
Croatian: Blister pakiranje: 30 tvrdih kapsula
English: REYATAZ with food and drink See section 3 How to take REYATAZ.
Croatian: REYATAZ s hranom i pićem Pogledajte dio 3.
English: b Ten patients had baseline phenotypic resistance to atazanavir + ritonavir (fold change [FC]>5.2).
Croatian: b Deset bolesnika imalo je na početku fenotipsku rezistenciju na atazanavir s ritonavirom (promjena ekspresije [FC] >5,2 puta).
English: REYATAZ (without ritonavir) has been studied in adult patients with severe renal impairment (n=20), including those on haemodialysis, at multiple doses of 400 mg once daily.
Croatian: REYATAZ (bez ritonavira) ispitan je u odraslih bolesnika s teškim oštećenjem funkcije bubrega (n=20), uključujući one na hemodijalizi, pomoću višestrukih doza od 400 mg jedanput na dan.
English: For children (at least 3 months of age and weighing at least 5 kg), your child's doctor will decide the right dose based on your child's weight.
Croatian: Za djecu (u dobi od 3 mjeseca i tjelesne težine od najmanje 5 kg), liječnik Vašeg djeteta odlučit će koja je doza ispravna na temelju tjelesne težine Vašeg djeteta.
English: Metabolic parameters
Croatian: Metabolički paramateri
English: The choice of REYATAZ in treatment experienced adult and paediatric patients should be based on individual viral resistance testing and the patient's treatment history (see sections 4.4 and 5.1).
Croatian: Odabir lijeka REYATAZ za liječenje već liječenih odraslih i pedijatrijskih bolesnika treba biti utemeljen na pojedinačnom testiranju virusne rezistencije i prethodnom liječenju pojedinog bolesnika (vidjeti dijelove 4.4 i 5.1).
English: Blister pack: 60 hard capsules
Croatian: Blister pakiranje: 60 tvrdih kapsula
English: Of importance, many studies were conducted with unboosted atazanavir, which is not the approved regimen of atazanavir.
Croatian: Važno je istaknuti da su mnoga ispitivanja provedena s nepojačanim atazanavirom, što nije odobren oblik liječenja atazanavirom.
English: If you have been told by your doctor that your child has an intolerance to some sugars, contact your doctor before giving this medicinal product to your child.
Croatian: Ako Vam je liječnik rekao da Vaše dijete ne podnosineke šećere, obratite se liječniku prije nego počnete davati svom djetetu ovaj lijek.
English: Other marked clinical laboratory abnormalities (Grade 3 or 4) reported in ≥ 2% of patients receiving regimens containing REYATAZ and one or more NRTIs included: elevated creatine kinase (7%), elevated alanine aminotransferase/serum glutamic-pyruvic transaminase (ALT/SGPT) (5%), low neutrophils (5%), elevated aspartate aminotransferase/serum glutamic-oxaloacetic transaminase (AST/SGOT) (3%), and elevated lipase (3%).
Croatian: Drugi značajni kliničko-laboratorijski poremećaji (3. ili 4. stupnja) zabilježeni u ≥ 2% bolesnika koji su primali terapijske protokole s lijekom REYATAZ i jednim ili više NRTI-jeva uključivali su: povišenu kreatin kinazu (7%), povišen omjer alanin aminotransferaze i serumske glutamin-piruvatne transaminaze (ALT/SGPT) (5%), nizak broj neutrofila (5%), povišen omjer aspartat aminotransferaze i serumske glutamat-oksaloctene transaminaze (AST/SGOT) (3%) i povišenu lipazu (3%).
English: Do not take sildenafil with REYATAZ when sildenafil is used for the treatment of pulmonary arterial hypertension.
Croatian: Nemojte uzimati sildenafil s lijekom REYATAZ kad se sildenafil primjenjuje za liječenje plućne arterijske hipertenzije.
English: There are no pharmacokinetic data available for REYATAZ with ritonavir in patients with renal insufficiency.
Croatian: Nema dostupnih farmakokinetičkih podataka za REYATAZ s ritonavirom u bolesnika s insuficijencijom bubrega.
English: In repeat-dose toxicity studies, conducted in mice, rats, and dogs, atazanavir-related findings were generally confined to the liver and included generally minimal to mild increases in serum bilirubin and liver enzymes, hepatocellular vacuolation and hypertrophy, and, in female mice only, hepatic singlecell necrosis.
Croatian: U ispitivanjima toksičnosti ponovljenih doza provedenih u miševa, štakora i pasa, nalazi povezani s atazanavirom općenito su bili ograničeni na jetru i uključivali su općenito minimalna do blaga povišenja serumskog bilirubina i jetrenih enzima, hepatocelularnu vakuolizaciju i hipertrofiju te, samo u ženki miša, nekrozu pojedinačnih jetrenih stanica.
English: Add 30 ml of the drink and mix with a spoon.
Croatian: Dodajte 30 ml pića i promiješajte žlicom
English: Administration of REYATAZ with ritonavir with either a light or a high-fat meal decreased the coefficient of variation of AUC and Cmax by approximately 25% compared to the fasting state.
Croatian: Primjena lijeka REYATAZ s ritonavirom uz lagani obrok ili obrok bogat mastima smanjila je koeficijent varijacije AUC i Cmax za približno 25% u usporedbi s onima natašte.
English: The appropriate option listed below is chosen for mixing and administration with liquid infant formula, beverage or food.
Croatian: 2. Treba izabrati odgovarajući način naveden dolje, za miješanje i primjenu s tekućom dojenačkom formulom, pićem ili hranom.
English: Driving and using machines If you feel dizzy or lightheaded, do not drive or use machines, and contact your doctor immediately.
Croatian: Ako osjetite omaglicu ili ošamućenost, nemojte voziti ili upravljati strojevima i odmah se obratite liječniku.
English: Consult the dosing table for the specific formulation (see Summary of Product Characteristics for REYATAZ capsules).
Croatian: Provjerite tablicu doziranja za određenu formulaciju (vidjeti Sažetak opisa svojstava lijeka za REYTAZ kapsule).